https://news.medxy.ai/zh/surgical-decisions-dementia/Medxy AIzh2026-08-22T10:17:23-07:00痴呆患者的外科决策：临床医生面临的挑战与洞见 https://news.medxy.ai/ja/dementia-surgery-decisions/Medxy AIja2026-08-22T10:17:06-07:00認知症患者の手術判断をどう支えるか：臨床現場の課題と示唆 https://news.medxy.ai/vi/surgery-decision-dementia/Medxy AIvi2026-08-22T10:16:43-07:00Ra quyết định phẫu thuật ở bệnh nhân sa sút trí tuệ: Thách thức và nhận định từ bác sĩ lâm sàng https://news.medxy.ai/zh/beyond-survival/Medxy AIzh2026-08-22T10:15:38-07:00超越生存：高风险结直肠癌肝转移肝切除术后健康相关生活质量的纵向研究 https://news.medxy.ai/ja/hepatic-resection-quality-of-life/Medxy AIja2026-08-22T10:15:20-07:00高リスク結腸直腸癌肝転移に対する肝切除後の健康関連QOL：生存を超えた縦断的検討 https://news.medxy.ai/vi/quality-of-life-liver-surgery/Medxy AIvi2026-08-22T10:15:02-07:00Vượt Qua Sống Còn: Chất lượng cuộc sống liên quan đến sức khỏe theo dõi dọc sau phẫu thuật cắt gan ở di căn gan do ung thư đại trực tràng nguy cơ cao https://news.medxy.ai/zh/cta-carotid-plaque/Medxy AIzh2026-08-22T10:13:49-07:00超越狭窄：CTA 识别颈动脉斑块钙化模式，如何预测卒中风险 https://news.medxy.ai/ja/carotid-plaque-calcification/Medxy AIja2026-08-22T10:13:30-07:00狭窄だけではない：CTAでみる頸動脈プラーク石灰化パターンが示す脳卒中リスク https://news.medxy.ai/vi/carotid-plaque-calcification/Medxy AIvi2026-08-22T10:13:08-07:00Vượt qua mức độ hẹp: Kiểu vôi hóa mảng xơ vữa động mạch cảnh trên CTA dự đoán nguy cơ đột quỵ như thế nào https://news.medxy.ai/zh/nordic-female-cancer-trends/Medxy AIzh2026-08-22T10:11:54-07:00北欧年轻女性子宫内膜癌、卵巢癌与宫颈癌发病、死亡及生存趋势：40年登记数据揭示的启示 https://news.medxy.ai/ja/nordic-gynecologic-cancer-trends/Medxy AIja2026-08-22T10:11:30-07:00ノルディック若年女性における子宮内膜癌・卵巣癌・子宮頸癌の罹患率、死亡率、生存率の推移――登録データ40年解析からの示唆 https://news.medxy.ai/vi/cancer-trends-nordic-women/Medxy AIvi2026-08-22T10:11:08-07:00Xu hướng tỷ lệ mắc, tử vong và sống còn của ung thư nội mạc tử cung, buồng trứng và cổ tử cung ở phụ nữ trẻ Bắc Âu: Góc nhìn từ dữ liệu đăng ký 40 năm https://news.medxy.ai/zh/gynecology-tumor-trials/Medxy AIzh2026-08-22T10:09:31-07:00妇科肿瘤学早期与晚期临床试验：试验完成、报告及种族/族裔少数群体入组趋势 https://news.medxy.ai/ja/gynecologic-tumor-trials/Medxy AIja2026-08-22T10:09:15-07:00婦人科腫瘍学における初期相試験と後期相試験の比較：試験完了・報告・人種的少数者登録の動向 https://news.medxy.ai/vi/gynecologic-cancer-stages/Medxy AIvi2026-08-22T10:08:53-07:00Thử nghiệm ung thư phụ khoa giai đoạn sớm và giai đoạn muộn: Xu hướng hoàn thành, báo cáo và tuyển chọn các nhóm thiểu số về chủng tộc và dân tộc https://news.medxy.ai/zh/hpv-infection-insights/Medxy AIzh2026-08-22T10:07:37-07:00持续性高危型 HPV 感染且无明显细胞学异常：阴道镜与组织学结局的临床启示 https://news.medxy.ai/ja/persistent-hrhpv-infection/Medxy AIja2026-08-22T10:07:21-07:00主要な細胞診異常がなくても見逃せない――持続的高リスクHPV感染とコルポスコピー・組織診の示唆 https://news.medxy.ai/vi/persistent-hrhpv-clinical-insights/Medxy AIvi2026-08-22T10:07:01-07:00Nhiễm hrHPV kéo dài dù tế bào học ít bất thường: Góc nhìn lâm sàng về kết quả soi cổ tử cung và mô học https://news.medxy.ai/zh/minimally-invasive-hysterectomy/Medxy AIzh2026-08-22T10:05:30-07:00微创子宫切除术中如何尽量减少子宫肌层细胞外溢：封闭式手工碎解术的作用评估 https://news.medxy.ai/ja/muscle-cell-leakage-control/Medxy AIja2026-08-22T10:05:11-07:00低侵襲子宮摘出術における筋層細胞漏出をいかに抑えるか：封じ込め下手動モルセレーションの意義を検証する https://news.medxy.ai/vi/morcellation-minimizing-leakage/Medxy AIvi2026-08-22T10:04:48-07:00Giảm thiểu rò rỉ tế bào cơ tử cung trong cắt tử cung xâm lấn tối thiểu: Vai trò của morcellation thủ công có bao chứa https://news.medxy.ai/zh/gut-microbiome-masld/Medxy AIzh2026-08-22T10:03:04-07:00肠道微生物群与代谢组学特征：预测 MASLD 与病毒性肝癌免疫治疗结局的新线索 https://news.medxy.ai/ja/masld-hcc-immunotherapy/Medxy AIja2026-08-22T10:02:44-07:00MASLDおよびウイルス性HCCにおける免疫療法予後予測因子としての腸内細菌叢とメタボロームシグネチャー https://news.medxy.ai/vi/gut-microbiota-metabolic-markers/Medxy AIvi2026-08-22T10:02:20-07:00Hệ vi sinh vật đường ruột và dấu ấn chuyển hóa: chỉ báo dự báo kết quả miễn dịch trị liệu ở HCC liên quan MASLD và viêm gan siêu vi https://news.medxy.ai/zh/pck1-deficiency-metabolic-checkpoint/Medxy AIzh2026-08-22T10:00:53-07:00PCK1缺乏通过12-HETE诱导CD8+ T细胞功能障碍促进MASH-HCC进展的代谢检查点作用 https://news.medxy.ai/ja/pck1-metabolic-checkpoint/Medxy AIja2026-08-22T10:00:34-07:0012-HETEによるCD8+ T細胞機能障害を介したMASH-HCC進展におけるPCK1欠損の代謝チェックポイントとしての役割 https://news.medxy.ai/vi/pck1-metabolic-control/Medxy AIvi2026-08-22T10:00:03-07:00Vai trò của thiếu hụt PCK1 như một điểm kiểm soát chuyển hóa trong thúc đẩy MASH-HCC qua rối loạn chức năng tế bào T CD8+ do 12-HETE https://news.medxy.ai/zh/kif13b-kpna2-ppara-axis/Medxy AIzh2026-08-22T09:58:32-07:00KIF13B-KPNA2-PPARα 轴：减轻酒精相关性肝脂肪变性的新靶点 https://news.medxy.ai/ja/kif13b-kpna2-pparalpha-axis/Medxy AIja2026-08-22T09:58:09-07:00KIF13B-KPNA2-PPARα軸：アルコール関連肝脂肪化を抑える新規標的 https://news.medxy.ai/vi/kif13b-kpna2-ppara-target/Medxy AIvi2026-08-22T09:57:48-07:00Trục KIF13B-KPNA2-PPARα: Mục tiêu mới tiềm năng để giảm gan nhiễm mỡ liên quan đến rượu https://news.medxy.ai/zh/stroke-ischemia-benefit/Medxy AIzh2026-08-22T09:55:54-07:00急性卒中中基线缺血负荷影响取栓前替奈普酶获益：来自 BRIDGE-TNK 试验的洞见 https://news.medxy.ai/ja/tnk-efficacy-stroke/Medxy AIja2026-08-22T09:55:35-07:00急性脳卒中における血栓回収療法前テネクテプラーゼの有効性はベースライン虚血負荷で変わる：BRIDGE-TNK試験からの知見 https://news.medxy.ai/vi/ischemia-level-tenecteplase/Medxy AIvi2026-08-22T09:55:18-07:00Mức độ thiếu máu cục bộ nền chi phối lợi ích của tenecteplase trước lấy huyết khối trong đột quỵ cấp: Góc nhìn từ thử nghiệm BRIDGE-TNK https://news.medxy.ai/zh/paramagnetic-lesions-ms-progress/Medxy AIzh2026-08-22T09:52:59-07:00顺磁性边缘病灶可预测多发性硬化进展：一项 5 年纵向研究的启示 https://news.medxy.ai/ja/ms-progression-predictors/Medxy AIja2026-08-22T09:52:38-07:00多発性硬化症における進行予測因子としての常磁性リム病変：5年間縦断研究からの知見 https://news.medxy.ai/vi/magnetic-lesions-ms/Medxy AIvi2026-08-22T09:52:17-07:00Lesion vành từ tính có dự báo tiến triển trong bệnh đa xơ cứng không? Bằng chứng từ nghiên cứu theo dõi 5 năm https://news.medxy.ai/zh/congenital-adrenal-hyperplasia-pregnancy/Medxy AIzh2026-08-22T09:50:39-07:00先天性肾上腺皮质增生症女性的生育与妊娠结局优化 https://news.medxy.ai/ja/congenital-adrenal-hyperplasia/Medxy AIja2026-08-22T09:50:20-07:00先天性副腎過形成女性における妊孕性と妊娠転帰の最適化 https://news.medxy.ai/vi/fertility-pregnancy-optimization/Medxy AIvi2026-08-22T09:49:57-07:00Tối ưu hóa khả năng sinh sản và kết cục thai kỳ ở phụ nữ mắc tăng sản thượng thận bẩm sinh https://news.medxy.ai/zh/octreotide-role/Medxy AIzh2026-08-22T09:48:17-07:00奥曲肽在分泌儿茶酚胺的嗜铬细胞瘤与副神经节瘤管理中的作用：一种有前景的辅助治疗 https://news.medxy.ai/ja/octreotide-role-2/Medxy AIja2026-08-22T09:48:00-07:00カテコールアミン分泌性褐色細胞腫・傍神経節腫におけるOctreotideの役割：有望な補助療法 https://news.medxy.ai/vi/octreotide-pheochromocytoma-treatment/Medxy AIvi2026-08-22T09:47:40-07:00Octreotide trong điều trị pheochromocytoma và paraganglioma tiết catecholamine: một liệu pháp bổ trợ đầy hứa hẹn https://news.medxy.ai/zh/gestational-diabetes-risks-3/Medxy AIzh2026-08-22T09:45:54-07:00妊娠期糖尿病：复发及长期2型糖尿病风险的族裔差异 https://news.medxy.ai/ja/66197-2/Medxy AIja2026-08-22T09:45:37-07:00妊娠糖尿病：人種・民族集団間における再発および将来の2型糖尿病リスク https://news.medxy.ai/vi/gestational-diabetes-risk-2/Medxy AIvi2026-08-22T09:45:20-07:00Đái tháo đường thai kỳ: Khác biệt theo sắc tộc trong nguy cơ tái phát và nguy cơ đái tháo đường type 2 lâu dài https://news.medxy.ai/zh/bari-therapy-duration/Medxy AIzh2026-08-22T09:43:54-07:00巴瑞替尼停药后新发1型糖尿病β细胞功能可维持多久？ https://news.medxy.ai/ja/beta-cell-function-persistence/Medxy AIja2026-08-22T09:43:37-07:00新規発症1型糖尿病におけるbaricitinib中止後のβ細胞機能の持続性 https://news.medxy.ai/vi/baricitinib-treatment-discontinuation/Medxy AIvi2026-08-22T09:43:19-07:00Baricitinib ngừng điều trị: Chức năng tế bào β còn được duy trì bao lâu ở đái tháo đường typ 1 khởi phát mới? https://news.medxy.ai/zh/mazdutide-weight-loss/Medxy AIzh2026-08-22T09:41:40-07:00Mazdutide：新型双重激动剂在肥胖与超重成人中显示显著减重效果 https://news.medxy.ai/ja/mazdutide-weight-loss-3/Medxy AIja2026-08-22T09:41:18-07:00Mazdutide：新規二重作動薬が肥満・過体重の成人で有意な体重減少を示す https://news.medxy.ai/vi/mazdutide-weight-loss-2/Medxy AIvi2026-08-22T09:40:58-07:00Mazdutide: Chất chủ vận kép mới cho thấy hiệu quả giảm cân đáng kể ở người lớn mắc béo phì hoặc thừa cân https://news.medxy.ai/zh/heart-failure-management/Medxy AIzh2026-08-22T09:39:18-07:00日本心力衰竭管理的进展：来自 JROADHF 与 JROADHF-NEXT 登记研究的启示 https://news.medxy.ai/ja/heart-failure-advances/Medxy AIja2026-08-22T09:39:02-07:00心不全診療はどう進歩したか――JROADHF／JROADHF-NEXTレジストリが示す日本の変化 https://news.medxy.ai/vi/heart-failure-management-advances/Medxy AIvi2026-08-22T09:38:44-07:00Những tiến bộ trong quản lý suy tim: Góc nhìn từ các cơ sở dữ liệu đăng ký JROADHF và JROADHF-NEXT https://news.medxy.ai/zh/endometriosis-thrombosis-risk/Medxy AIzh2026-08-22T09:37:32-07:00子宫内膜异位症与静脉血栓栓塞长期风险升高相关：来自丹麦全国队列研究的启示 https://news.medxy.ai/ja/endometriosis-thrombosis-risk-2/Medxy AIja2026-08-22T09:37:15-07:00子宮内膜症は静脈血栓塞栓症の長期リスク上昇と関連：デンマーク全国コホート研究からの知見 https://news.medxy.ai/vi/endometriosis-blood-clots/Medxy AIvi2026-08-22T09:36:51-07:00Lạc nội mạc tử cung liên quan đến nguy cơ huyết khối tĩnh mạch thuyên tắc dài hạn tăng cao: Góc nhìn từ nghiên cứu đoàn hệ toàn quốc tại Đan Mạch https://news.medxy.ai/zh/myeloid-cells-hfpef/Medxy AIzh2026-08-22T09:35:15-07:00揭示无菌性炎症在 HFpEF 右心室功能障碍中的髓系细胞作用 https://news.medxy.ai/ja/right-ventricle-hfpef/Medxy AIja2026-08-22T09:34:58-07:00無菌性炎症が明かすHFpEFにおける右室機能障害と骨髄系細胞の役割 https://news.medxy.ai/vi/myeloid-cells-hfpef-2/Medxy AIvi2026-08-22T09:34:38-07:00Vai trò của tế bào myeloid trong rối loạn chức năng thất phải ở HFpEF: bằng chứng từ viêm vô khuẩn https://news.medxy.ai/zh/bempedoic-acid-results/Medxy AIzh2026-08-22T09:32:30-07:00Bempedoic acid在他汀不耐受的外周动脉疾病患者中显著减少肢体和心血管事件：来自CLEAR Outcomes试验的启示 https://news.medxy.ai/ja/66135-2/Medxy AIja2026-08-22T09:32:12-07:00末梢動脈疾患を有しスタチン不耐容の患者におけるベムペド酸と初回および再発の四肢関連転帰：CLEAR Outcomes試験からの知見 https://news.medxy.ai/vi/bempedoic-acid-benefits/Medxy AIvi2026-08-22T09:31:48-07:00Axit bempedoic làm giảm rõ rệt biến cố chi và tim mạch ở bệnh nhân bệnh động mạch ngoại biên không dung nạp statin: Góc nhìn từ thử nghiệm CLEAR Outcomes https://news.medxy.ai/zh/cervical-cerclage-prevention/Medxy AIzh2026-08-22T08:39:55-07:00高位还是低位经阴道宫颈环扎术更能预防早产？C-STICH试验二次分析揭示新线索 https://news.medxy.ai/ja/66123-2/Medxy AIja2026-08-22T08:39:36-07:00早産予防における高位対低位経腟頸管縫縮術：C-STICH試験の二次解析からの知見 https://news.medxy.ai/vi/66122-2/Medxy AIvi2026-08-22T08:39:14-07:00So sánh kỹ thuật khâu vòng cổ tử cung qua đường âm đạo ở vị trí cao và thấp nhằm ngăn ngừa sinh non: Những hiểu biết từ phân tích thứ cấp của thử nghiệm C-STICH https://news.medxy.ai/divergent-roles-of-federal-and-industry-sponsors-in-us-cancer-clinical-trials-insights-from-2008-to-2024/Medxy AIen2026-08-22T08:37:39-07:00Divergent Roles of Federal and Industry Sponsors in US Cancer Clinical Trials: Insights from 2008 to 2024 https://news.medxy.ai/decoding-systemic-inflammation-in-long-covid-and-autoimmune-diseases-the-role-of-intestinal-flagellin-and-the-tlr5-il-15-ara-axis/Medxy AIen2026-08-22T08:37:26-07:00Decoding Systemic Inflammation in Long COVID and Autoimmune Diseases: The Role of Intestinal Flagellin and the TLR5-IL-15-ARA Axis https://news.medxy.ai/zh/federal-vs-industry-funding-2/Medxy AIzh2026-08-22T08:15:58-07:00联邦与行业资助在美国癌症临床试验中的分工差异：2008—2024 年研究洞见 https://news.medxy.ai/ja/us-cancer-trial-sponsors/Medxy AIja2026-08-22T08:15:41-07:00米国がん臨床試験における連邦スポンサーと産業スポンサーの異なる役割：2008年から2024年の知見 https://news.medxy.ai/vi/federal-vs-industry-cancer-trials/Medxy AIvi2026-08-22T08:15:13-07:00Vai trò khác biệt của tài trợ liên bang và công nghiệp trong các thử nghiệm lâm sàng ung thư tại Hoa Kỳ: Những phát hiện từ giai đoạn 2008–2024 https://news.medxy.ai/zh/long-covid-inflammation/Medxy AIzh2026-08-22T08:13:26-07:00解析长新冠与自身免疫病中的全身炎症：肠道鞭毛蛋白及TLR5-IL-15-ARA轴的关键作用 https://news.medxy.ai/ja/long-covid-autoimmune-inflammation/Medxy AIja2026-08-22T08:13:07-07:00long COVIDと自己免疫疾患における全身性炎症の解読：腸内フラジェリンとTLR5-IL-15-ARA軸の役割 https://news.medxy.ai/vi/long-covid-autoimmune/Medxy AIvi2026-08-22T08:12:43-07:00Giải mã viêm hệ thống trong long COVID và các bệnh tự miễn: vai trò của flagellin đường ruột và trục TLR5-IL-15-ARA https://news.medxy.ai/impact-of-palate-repair-timing-within-first-15-months-on-early-speech-development-in-children-with-cleft-palate/Medxy AIen2026-08-21T11:28:05-07:00Impact of Palate Repair Timing within First 15 Months on Early Speech Development in Children with Cleft Palate https://news.medxy.ai/pembrolizumab-plus-quad-shot-radiotherapy-a-promising-approach-for-recurrent-unresectable-head-and-neck-cancer/Medxy AIen2026-08-21T11:27:54-07:00Pembrolizumab Plus Quad-Shot Radiotherapy: A Promising Approach for Recurrent, Unresectable Head and Neck Cancer https://news.medxy.ai/enhancing-vestibular-migraine-rehabilitation-with-virtual-reality-a-randomized-controlled-trial/Medxy AIen2026-08-21T11:27:40-07:00Enhancing Vestibular Migraine Rehabilitation with Virtual Reality: A Randomized Controlled Trial https://news.medxy.ai/expanding-pediatric-cochlear-implant-indications-multicenter-evidence-supports-safety-and-efficacy-in-younger-children-and-those-with-residual-hearing/Medxy AIen2026-08-21T11:27:24-07:00Expanding Pediatric Cochlear Implant Indications: Multicenter Evidence Supports Safety and Efficacy in Younger Children and Those with Residual Hearing https://news.medxy.ai/impact-of-trauma-on-social-risk-insights-from-serial-hospital-data-screening/Medxy AIen2026-08-21T11:27:11-07:00Impact of Trauma on Social Risk: Insights from Serial Hospital Data Screening https://news.medxy.ai/early-uptake-of-broad-spectrum-antibiotic-prophylaxis-in-pancreatoduodenectomy-translating-trial-evidence-into-practice/Medxy AIen2026-08-21T11:26:58-07:00Early Uptake of Broad-Spectrum Antibiotic Prophylaxis in Pancreatoduodenectomy: Translating Trial Evidence into Practice https://news.medxy.ai/evaluating-preoperative-high-dose-corticosteroids-in-digestive-cancer-surgery-insights-from-a-large-multicenter-randomized-trial/Medxy AIen2026-08-21T11:26:44-07:00Evaluating Preoperative High-Dose Corticosteroids in Digestive Cancer Surgery: Insights from a Large Multicenter Randomized Trial https://news.medxy.ai/new-2026-multisociety-guidelines-for-atypical-breast-lesions-and-lcis-what-clinicians-need-to-know/Medxy AIen2026-08-21T11:26:30-07:00New 2026 Multisociety Guidelines for Atypical Breast Lesions and LCIS: What Clinicians Need to Know https://news.medxy.ai/navigating-intraoperative-challenges-in-robot-assisted-minimally-invasive-esophagectomy-incidence-management-and-surgical-outcomes/Medxy AIen2026-08-21T11:26:15-07:00Navigating Intraoperative Challenges in Robot-assisted Minimally Invasive Esophagectomy: Incidence, Management, and Surgical Outcomes https://news.medxy.ai/patterns-and-implications-of-local-regrowth-after-neoadjuvant-chemoradiotherapy-in-esophageal-cancer-insights-from-the-sano-trial/Medxy AIen2026-08-21T11:25:59-07:00Patterns and Implications of Local Regrowth After Neoadjuvant Chemoradiotherapy in Esophageal Cancer: Insights from the SANO Trial https://news.medxy.ai/enhancing-patient-engagement-in-gynecologic-oncology-clinical-trials-through-a-pilot-patient-ambassador-program/Medxy AIen2026-08-21T11:25:45-07:00Enhancing Patient Engagement in Gynecologic Oncology Clinical Trials Through a Pilot Patient Ambassador Program https://news.medxy.ai/niraparib-versus-platinum-taxane-chemotherapy-as-neoadjuvant-treatment-in-advanced-hr-deficient-ovarian-cancer-insights-from-the-opal-phase-2-trial/Medxy AIen2026-08-21T11:25:29-07:00Niraparib Versus Platinum-Taxane Chemotherapy as Neoadjuvant Treatment in Advanced HR-Deficient Ovarian Cancer: Insights from the OPAL Phase 2 Trial https://news.medxy.ai/bridging-perspectives-patient-and-clinician-views-on-postpartum-venous-thromboembolism-risk-and-thromboprophylaxis-use/Medxy AIen2026-08-21T11:25:15-07:00Bridging Perspectives: Patient and Clinician Views on Postpartum Venous Thromboembolism Risk and Thromboprophylaxis Use https://news.medxy.ai/high-versus-low-vaginal-cerclage-effects-on-pregnancy-outcomes-in-women-at-high-risk-of-preterm-birth/Medxy AIen2026-08-21T11:25:00-07:00High Versus Low Vaginal Cerclage: Effects on Pregnancy Outcomes in Women at High Risk of Preterm Birth https://news.medxy.ai/minimally-invasive-prediction-models-for-intra-amniotic-infection-and-early-delivery-risk-in-preterm-labor/Medxy AIen2026-08-21T11:24:44-07:00Minimally Invasive Prediction Models for Intra-Amniotic Infection and Early Delivery Risk in Preterm Labor https://news.medxy.ai/gynecologic-cancer-disparities/Medxy AIen2026-08-21T11:24:20-07:00Disparities in Gynecologic Cancer Diagnosis in the U.S. (2001–2019): The Roles of Race, Social Vulnerability, and Specialist Access https://news.medxy.ai/innovative-single-port-transabdominal-hysteroscopic-technique-for-perforated-iud-removal/Medxy AIen2026-08-21T11:24:05-07:00Innovative Single-Port Transabdominal Hysteroscopic Technique for Perforated IUD Removal https://news.medxy.ai/recurrent-severe-hypertensive-disorders-in-pregnancy-evaluating-risks-and-outcomes-for-future-pregnancies/Medxy AIen2026-08-21T11:23:51-07:00Recurrent Severe Hypertensive Disorders in Pregnancy: Evaluating Risks and Outcomes for Future Pregnancies https://news.medxy.ai/targeting-nek7-mediated-egfr-phosphorylation-to-overcome-lenvatinib-resistance-in-hepatocellular-carcinoma/Medxy AIen2026-08-21T11:23:39-07:00Targeting NEK7-Mediated EGFR Phosphorylation to Overcome Lenvatinib Resistance in Hepatocellular Carcinoma https://news.medxy.ai/multiomic-profiling-and-machine-learning-reveal-distinct-molecular-subtypes-of-cholangiocarcinoma-and-identify-tnk1-as-a-novel-therapeutic-target/Medxy AIen2026-08-21T11:23:28-07:00Multiomic Profiling and Machine Learning Reveal Distinct Molecular Subtypes of Cholangiocarcinoma and Identify TNK1 as a Novel Therapeutic Target https://news.medxy.ai/rethinking-meningioma-management-incidence-surge-amid-stable-treatment-and-extensive-imaging-surveillance/Medxy AIen2026-08-21T11:23:05-07:00Rethinking Meningioma Management: Incidence Surge Amid Stable Treatment and Extensive Imaging Surveillance https://news.medxy.ai/metrnl-a-novel-inhibitor-of-platelet-activation-targeting-cd36-to-mitigate-thrombosis-and-acute-myocardial-injury/Medxy AIen2026-08-21T11:22:53-07:00Metrnl: A Novel Inhibitor of Platelet Activation Targeting CD36 to Mitigate Thrombosis and Acute Myocardial Injury https://news.medxy.ai/semaglutide-inflammation-risk/Medxy AIen2026-08-21T11:22:40-07:00Semaglutide’s Impact on Inflammation and Cardiovascular Risk in Overweight Patients: Insights from the SELECT Trial https://news.medxy.ai/ai-ecg-for-detecting-structural-heart-disease-in-the-community-evaluating-real-world-applicability-in-the-prevue-valve-study/Medxy AIen2026-08-21T11:22:28-07:00AI-ECG for Detecting Structural Heart Disease in the Community: Evaluating Real-World Applicability in the PREVUE-VALVE Study https://news.medxy.ai/unmasking-silent-heart-failure-in-diabetes-insights-from-the-tartan-hf-trial/Medxy AIen2026-08-21T11:22:14-07:00Unmasking Silent Heart Failure in Diabetes: Insights from the TARTAN-HF Trial https://news.medxy.ai/unveiling-hidden-immune-signatures-in-cardiovascular-disease-through-single-cell-multi-omics/Medxy AIen2026-08-21T11:22:02-07:00Unveiling Hidden Immune Signatures in Cardiovascular Disease Through Single-Cell Multi-Omics https://news.medxy.ai/runx1-driven-endothelial-to-mesenchymal-transition-a-novel-mechanistic-link-and-therapeutic-target-in-lmna-cardiomyopathy/Medxy AIen2026-08-21T11:21:50-07:00RUNX1-Driven Endothelial-to-Mesenchymal Transition: A Novel Mechanistic Link and Therapeutic Target in LMNA Cardiomyopathy https://news.medxy.ai/left-atrial-dysfunction-and-vutrisiran-efficacy-in-transthyretin-amyloid-cardiomyopathy-insights-from-the-helios-b-trial/Medxy AIen2026-08-21T11:21:38-07:00Left Atrial Dysfunction and Vutrisiran Efficacy in Transthyretin Amyloid Cardiomyopathy: Insights from the HELIOS-B Trial https://news.medxy.ai/age-specific-excess-healthcare-burden-of-diabetes-beyond-traditional-complications/Medxy AIen2026-08-21T11:21:27-07:00Age-Specific Excess Healthcare Burden of Diabetes: Beyond Traditional Complications https://news.medxy.ai/supar-as-a-novel-marker-for-residual-inflammatory-risk-beyond-hs-crp-in-type-2-diabetes-with-coronary-artery-disease/Medxy AIen2026-08-21T11:21:08-07:00suPAR as a Novel Marker for Residual Inflammatory Risk Beyond hs-CRP in Type 2 Diabetes with Coronary Artery Disease https://news.medxy.ai/circulating-mir-1-3p-precedes-adrenarche-and-modulates-adrenocortical-steroidogenesis-via-protein-kinase-c-signaling/Medxy AIen2026-08-21T11:20:57-07:00Circulating miR-1-3p Precedes Adrenarche and Modulates Adrenocortical Steroidogenesis via Protein Kinase C Signaling https://news.medxy.ai/dulaglutide-versus-insulin-in-adolescents-with-thalassaemia-induced-diabetes-improving-glycaemic-control-and-metabolic-health-in-a-high-risk-population/Medxy AIen2026-08-21T11:20:44-07:00Dulaglutide Versus Insulin in Adolescents With Thalassaemia-Induced Diabetes: Improving Glycaemic Control and Metabolic Health in a High-Risk Population https://news.medxy.ai/menopausal-transition-and-thyroid-function-deciphering-the-impact-beyond-aging-in-midlife-women/Medxy AIen2026-08-21T11:20:32-07:00Menopausal Transition and Thyroid Function: Deciphering the Impact Beyond Aging in Midlife Women https://news.medxy.ai/long-term-fatigue-in-differentiated-thyroid-cancer-survivors-early-predictors-and-the-non-impact-of-thyrotropin-suppression/Medxy AIen2026-08-21T11:20:19-07:00Long-Term Fatigue in Differentiated Thyroid Cancer Survivors: Early Predictors and the Non-Impact of Thyrotropin Suppression https://news.medxy.ai/delineating-the-roles-of-federal-and-industry-sponsorship-in-us-cancer-clinical-trials/Medxy AIen2026-08-21T11:20:02-07:00Delineating the Roles of Federal and Industry Sponsorship in US Cancer Clinical Trials https://news.medxy.ai/refining-treatment-monitoring-in-patients-with-relapsing-multiple-sclerosis-based-on-changes-on-neurofilament-light-chain-z-scores/Medxy AIen2026-08-21T11:19:37-07:00Refining Treatment Monitoring in Patients With Relapsing Multiple Sclerosis Based on Changes on Neurofilament Light Chain Z-Scores https://news.medxy.ai/ldl-c-reduction/Medxy AIen2026-08-21T11:19:24-07:00Optimizing LDL-C Reduction Strategies in Ischemic Stroke: Impact of Achieving ≥50% LDL-C Reduction from Baseline https://news.medxy.ai/colchicine-for-secondary-prevention-after-stroke-according-to-the-presence-of-atherosclerosis-clinical-evidence-and-implications/Medxy AIen2026-08-21T11:19:10-07:00Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis: Clinical Evidence and Implications https://news.medxy.ai/unraveling-the-gut-lung-axis-intestinal-flagellin-as-a-driver-of-multisystem-inflammation-via-the-tlr5-il-15-ara-pathway/Medxy AIen2026-08-21T11:18:59-07:00Unraveling the Gut-Lung Axis: Intestinal Flagellin as a Driver of Multisystem Inflammation via the TLR5-IL-15-ARA Pathway https://news.medxy.ai/targeting-nsun6-deficiency-to-overcome-immune-suppression-in-pancreatic-cancer-insights-into-the-kdm5a-ccl2-macrophage-axis/Medxy AIen2026-08-21T11:18:47-07:00Targeting NSUN6 Deficiency to Overcome Immune Suppression in Pancreatic Cancer: Insights into the KDM5A-CCL2-Macrophage Axis https://news.medxy.ai/zh/palate-repair-timing/Medxy AIzh2026-08-21T10:54:33-07:00腭修复越早越有利？15个月内手术时机与儿童早期言语发育的关系 https://news.medxy.ai/ja/palate-repair-timing-2/Medxy AIja2026-08-21T10:54:16-07:00口蓋裂児の早期発話発達に対する、15か月未満での口蓋修復時期の影響 https://news.medxy.ai/vi/cleft-palate-repair-timing/Medxy AIvi2026-08-21T10:53:56-07:00Thời điểm sửa chữa khẩu cái trong 15 tháng đầu đời ảnh hưởng thế nào đến phát triển lời nói sớm ở trẻ hở hàm ếch https://news.medxy.ai/zh/pembrolizumab-radiotherapy/Medxy AIzh2026-08-21T10:52:49-07:00帕博利珠单抗联合四照射放疗：复发、不可切除头颈癌的潜力方案 https://news.medxy.ai/ja/head-neck-cancer-strategy/Medxy AIja2026-08-21T10:52:33-07:00再発・切除不能頭頸部癌に挑む新戦略：ペムブロリズマブ併用quad-shot放射線療法の可能性 https://news.medxy.ai/vi/pembrolizumab-radiation-therapy/Medxy AIvi2026-08-21T10:52:14-07:00Pembrolizumab phối hợp xạ trị quad-shot: hướng đi đầy triển vọng cho ung thư đầu và cổ tái phát không thể phẫu thuật https://news.medxy.ai/zh/vr-vestibular-rehabilitation/Medxy AIzh2026-08-21T10:50:50-07:00虚拟现实加持前庭康复：前庭性偏头痛随机对照试验证实症状与平衡控制获益 https://news.medxy.ai/ja/vestibular-migraine-rehabilitation/Medxy AIja2026-08-21T10:50:28-07:00仮想現実を活用した前庭リハビリテーションで前庭性片頭痛の回復を高める：ランダム化比較試験 https://news.medxy.ai/vi/migraine-vestibular-recovery/Medxy AIvi2026-08-21T10:50:06-07:00Tăng cường phục hồi migraine tiền đình bằng thực tế ảo: Kết quả từ một thử nghiệm ngẫu nhiên có đối chứng https://news.medxy.ai/zh/cochlear-implant-expansion/Medxy AIzh2026-08-21T10:48:47-07:00儿童人工耳蜗适应证再拓宽：多中心证据支持更小年龄及残余听力儿童的安全性与有效性 https://news.medxy.ai/ja/expanded-pediatric-cochlear-implant/Medxy AIja2026-08-21T10:48:30-07:00小児人工内耳の適応拡大へ――低年齢児と残存聴力例を支持する多施設エビデンス https://news.medxy.ai/vi/cochlear-implant-expansion-2/Medxy AIvi2026-08-21T10:48:09-07:00Mở rộng chỉ định cấy ốc tai điện tử ở trẻ em: Bằng chứng đa trung tâm ủng hộ độ an toàn và hiệu quả ở trẻ nhỏ hơn và trẻ còn thính lực tồn dư https://news.medxy.ai/zh/trauma-social-risk-impact/Medxy AIzh2026-08-21T10:44:03-07:00创伤对社会风险的影响：基于连续住院数据筛查的研究洞见 https://news.medxy.ai/ja/trauma-social-risk-impact-2/Medxy AIja2026-08-21T10:43:48-07:00外傷が社会的リスクに及ぼす影響：連続的病院スクリーニングデータからの知見 https://news.medxy.ai/vi/trauma-social-risk/Medxy AIvi2026-08-21T10:43:27-07:00Chấn thương làm gia tăng nguy cơ xã hội: Nhận định từ dữ liệu sàng lọc liên tiếp tại bệnh viện https://news.medxy.ai/zh/early-antibiotic-use-pancreaticoduodenectomy/Medxy AIzh2026-08-21T10:42:21-07:00胰十二指肠切除术广谱抗生素预防用药的早期应用：从试验证据到临床实践的转化 https://news.medxy.ai/ja/early-antibiotic-prophylaxis/Medxy AIja2026-08-21T10:41:58-07:00膵頭十二指腸切除術における広域抗菌薬予防投与の早期導入：試験エビデンスの実臨床への橋渡し https://news.medxy.ai/vi/early-broad-spectrum-antibiotics/Medxy AIvi2026-08-21T10:41:36-07:00Dự phòng kháng sinh phổ rộng được áp dụng sớm trong phẫu thuật cắt tá tụy: Từ bằng chứng thử nghiệm đến thực hành https://news.medxy.ai/zh/preoperative-steroids-cancer-surgery/Medxy AIzh2026-08-21T10:40:30-07:00消化系统癌症手术中术前大剂量糖皮质激素的价值：来自大型多中心随机试验的证据 https://news.medxy.ai/ja/preoperative-steroids-cancer/Medxy AIja2026-08-21T10:40:13-07:00消化器がん手術における術前高用量コルチコステロイド：大規模多施設無作為化試験から見えたもの https://news.medxy.ai/vi/high-dose-corticosteroids-surgery/Medxy AIvi2026-08-21T10:39:56-07:00Corticosteroids liều cao trước phẫu thuật trong phẫu thuật ung thư tiêu hóa: Góc nhìn từ một thử nghiệm ngẫu nhiên đa trung tâm quy mô lớn https://news.medxy.ai/ja/atypical-breast-lesions-lcis/Medxy AIja2026-08-21T10:38:43-07:002026年版 多学会ガイドラインで整理された異型乳腺病変とLCIS：臨床医が押さえるべき要点 https://news.medxy.ai/vi/atypical-breast-lesions-guide/Medxy AIvi2026-08-21T10:38:15-07:00Hướng dẫn đa chuyên khoa 2026 về tổn thương vú không điển hình và LCIS: Bác sĩ lâm sàng cần biết gì https://news.medxy.ai/zh/2026-breast-lesion-guidelines/Medxy AIzh2026-08-21T10:37:46-07:002026年多学会乳腺非典型病变与LCIS新指南：临床医生需要掌握的要点 https://news.medxy.ai/zh/robotic-esophagectomy-challenges/Medxy AIzh2026-08-21T10:35:56-07:00机器人辅助微创食管切除术中的术中挑战：发生率、处理与手术结局 https://news.medxy.ai/ja/robotic-esophagectomy-troubles/Medxy AIja2026-08-21T10:35:39-07:00ロボット支援低侵襲食道切除術における術中トラブルを読み解く：発生頻度、対応、手術成績 https://news.medxy.ai/vi/robotic-esophagectomy-challenges-2/Medxy AIvi2026-08-21T10:35:21-07:00Vượt qua thách thức trong mổ ở cắt thực quản xâm lấn tối thiểu có hỗ trợ robot: tỷ lệ mắc, xử trí và kết quả phẫu thuật https://news.medxy.ai/zh/esophageal-cancer-local-recurrence/Medxy AIzh2026-08-21T10:34:07-07:00食管癌新辅助放化疗后局部再生长的模式与临床意义：来自SANO试验的观察 https://news.medxy.ai/ja/esophageal-cancer-recurrence/Medxy AIja2026-08-21T10:33:46-07:00食道癌における術前化学放射線療法後の局所再増殖パターンと臨床的意義：SANO試験からの知見 https://news.medxy.ai/vi/local-recurrence-esophageal-cancer/Medxy AIvi2026-08-21T10:33:27-07:00Kiểu tái phát tại chỗ sau hóa xạ trị tân bổ trợ trong ung thư thực quản: Góc nhìn từ thử nghiệm SANO https://news.medxy.ai/zh/patient-ambassador-pilot/Medxy AIzh2026-08-21T10:32:16-07:00患者大使试点项目助力提升妇科肿瘤临床试验参与度 https://news.medxy.ai/ja/gynecologic-tumor-trial/Medxy AIja2026-08-21T10:31:58-07:00患者アンバサダー・プログラムで高める婦人科腫瘍臨床試験への参加意欲 https://news.medxy.ai/vi/65942-2/Medxy AIvi2026-08-21T10:31:37-07:00Đánh giá chương trình đại sứ bệnh nhân nhằm nâng cao kiến ​​thức về thử nghiệm lâm sàng và ý định thảo luận về các thử nghiệm ung thư phụ khoa https://news.medxy.ai/zh/opal2-niraparib-ovarian-cancer/Medxy AIzh2026-08-21T10:30:25-07:00OPAL 2 期研究解读：niraparib 作为晚期 HR 缺陷卵巢癌新辅助治疗不及铂类-紫杉烷化疗 https://news.medxy.ai/ja/65933-2/Medxy AIja2026-08-21T10:30:08-07:00新規診断された相同組換え修復欠損（HRD）を有するIII/IV期卵巣癌患者における術前化学療法としてのニラパリブとプラチナ製剤・タキサン系薬剤併用療法の比較：OPAL第II相試験コホートCの成績 https://news.medxy.ai/vi/niraparib-vs-chemotherapy/Medxy AIvi2026-08-21T10:29:50-07:00Niraparib so với hóa trị platinum-taxane trong điều trị trước phẫu thuật ung thư buồng trứng tiến triển có thiếu hụt HR: Góc nhìn từ thử nghiệm OPAL pha 2 https://news.medxy.ai/zh/postpartum-thrombosis-risk/Medxy AIzh2026-08-21T10:28:37-07:00跨越认知鸿沟：患者与临床医生对产后静脉血栓栓塞风险及血栓预防使用的看法 https://news.medxy.ai/ja/65924-2/Medxy AIja2026-08-21T10:28:22-07:00認識のギャップを埋める：産後の静脈血栓塞栓症リスクおよび血栓予防策の実施に関する患者と医療従事者の見解 https://news.medxy.ai/vi/venous-thromboembolism-awareness/Medxy AIvi2026-08-21T10:28:01-07:00Từ góc nhìn bệnh nhân đến bác sĩ: Nhận thức về nguy cơ huyết khối tĩnh mạch thuyên tắc sau sinh và việc sử dụng dự phòng https://news.medxy.ai/zh/cervical-cerclage-benefits/Medxy AIzh2026-08-21T10:24:11-07:00高位还是低位宫颈环扎更有利？对高早产风险女性妊娠结局的影响 https://news.medxy.ai/ja/transvaginal-cervical-cerclage/Medxy AIja2026-08-21T10:23:50-07:00高位と低位の経膣的頸管縫縮術：早産高リスク女性の妊娠転帰への影響 https://news.medxy.ai/vi/cervical-suture-impact/Medxy AIvi2026-08-21T10:23:28-07:00Khâu cổ tử cung âm đạo cao hay thấp: Ảnh hưởng đến kết cục thai kỳ ở phụ nữ có nguy cơ sinh non cao https://news.medxy.ai/zh/preterm-labor-infection-model/Medxy AIzh2026-08-21T10:22:10-07:00早产临产中宫内感染与早产风险的微创预测模型 https://news.medxy.ai/ja/amnion-infection-risk/Medxy AIja2026-08-21T10:21:48-07:00早産陣痛における羊膜内感染と早期分娩リスクを予測する低侵襲モデル https://news.medxy.ai/vi/infection-prediction-models/Medxy AIvi2026-08-21T10:21:26-07:00Các mô hình dự đoán ít xâm lấn về nhiễm trùng trong buồng ối và nguy cơ sinh sớm ở chuyển dạ sinh non https://news.medxy.ai/zh/us-gynecologic-cancer-disparities/Medxy AIzh2026-08-21T10:19:57-07:00美国妇科癌症诊断差异（2001—2019）：种族、社会脆弱性与专科可及性的作用 https://news.medxy.ai/ja/gynecological-cancer-disparities-us/Medxy AIja2026-08-21T10:19:33-07:00米国における婦人科がん診断の格差（2001～2019年）――人種、社会的脆弱性、専門医アクセスの影響 https://news.medxy.ai/vi/gynecologic-cancer-disparities-2/Medxy AIvi2026-08-21T10:19:09-07:00Chênh lệch trong chẩn đoán ung thư phụ khoa tại Hoa Kỳ (2001–2019): Vai trò của chủng tộc, mức độ tổn thương xã hội và khả năng tiếp cận bác sĩ chuyên khoa https://news.medxy.ai/zh/single-port-hysteroscopic-iud-removal/Medxy AIzh2026-08-21T10:17:50-07:00单孔经腹宫腔镜取出穿孔IUD：微创新技术 https://news.medxy.ai/ja/innovative-iud-removal/Medxy AIja2026-08-21T10:17:34-07:00穿孔IUD摘出に対する革新的な単一ポート経腹的子宮鏡手技 https://news.medxy.ai/vi/hysteroscopy-technique/Medxy AIvi2026-08-21T10:17:10-07:00Kỹ thuật nội soi buồng tử cung xuyên thành bụng một cổng: hướng tiếp cận mới để lấy bỏ IUD bị thủng https://news.medxy.ai/zh/severe-pregnancy-hypertension/Medxy AIzh2026-08-21T10:15:55-07:00严重妊娠期高血压疾病易复发：后续妊娠风险与结局评估 https://news.medxy.ai/ja/severe-pregnancy-hypertension-2/Medxy AIja2026-08-21T10:15:36-07:00重症妊娠高血圧症候群の再発を追う：将来妊娠におけるリスクと転帰の評価 https://news.medxy.ai/vi/severe-hypertension-pregnancy/Medxy AIvi2026-08-21T10:15:16-07:00Rối loạn tăng huyết áp nặng trong thai kỳ tái phát: đánh giá nguy cơ và kết cục ở những lần mang thai sau https://news.medxy.ai/zh/nek7-egfr-lenvatinib-resistance/Medxy AIzh2026-08-21T10:13:47-07:00靶向NEK7介导的EGFR磷酸化：破解肝细胞癌仑伐替尼耐药的新策略 https://news.medxy.ai/ja/overcoming-lenvatinib-resistance/Medxy AIja2026-08-21T10:13:25-07:00NEK7によるEGFRリン酸化を標的にして肝細胞癌のレンバチニブ抵抗性を克服する https://news.medxy.ai/vi/overcome-lenvatinib-resistance/Medxy AIvi2026-08-21T10:13:05-07:00Nhắm vào phosphoryl hóa EGFR do NEK7 trung gian để vượt qua kháng lenvatinib trong ung thư biểu mô tế bào gan https://news.medxy.ai/zh/cholangiocarcinoma-subtypes/Medxy AIzh2026-08-21T10:11:36-07:00多组学与机器学习揭示胆管癌分子亚型，并确定TNK1为新型治疗靶点 https://news.medxy.ai/ja/multimomics-tnk1/Medxy AIja2026-08-21T10:11:17-07:00マルチオミクスと機械学習が明らかにした胆管癌の新規分子サブタイプと治療標的 TNK1 https://news.medxy.ai/vi/multi-omics-machine-learning/Medxy AIvi2026-08-21T10:10:55-07:00Đa omics và machine learning làm rõ các phân nhóm phân tử của ung thư đường mật, xác định TNK1 là đích điều trị mới https://news.medxy.ai/zh/nsun6-pancreatic-cancer/Medxy AIzh2026-08-21T10:09:26-07:00靶向NSUN6缺失逆转胰腺癌免疫抑制：聚焦KDM5A-CCL2-巨噬细胞轴 https://news.medxy.ai/ja/65820-2/Medxy AIja2026-08-21T10:09:09-07:00NSUN6の欠損は、KDM5A-CCL2-マクロファージ軸を介して膵臓がんにおける免疫抑制を惹起する https://news.medxy.ai/vi/fix-nsun6-immune-suppression/Medxy AIvi2026-08-21T10:08:48-07:00Nhắm vào thiếu hụt NSUN6 để khắc phục ức chế miễn dịch trong ung thư tụy: Góc nhìn về trục KDM5A-CCL2-đại thực bào https://news.medxy.ai/zh/gut-lung-axis/Medxy AIzh2026-08-21T09:40:42-07:00揭开肠-肺轴之谜：肠道鞭毛蛋白通过TLR5-IL-15-ARA通路驱动多系统炎症 https://news.medxy.ai/ja/intestinal-lung-connection/Medxy AIja2026-08-21T09:40:24-07:00腸-肺相関の新機序：TLR5-IL-15-ARA経路を介して多臓器炎症を誘導する腸管フラジェリン https://news.medxy.ai/vi/gut-lung-axis-2/Medxy AIvi2026-08-21T09:40:03-07:00Giải mã trục ruột-phổi: Flagellin đường ruột thúc đẩy viêm đa hệ thống qua con đường TLR5-IL-15-ARA https://news.medxy.ai/zh/colchicine-stroke-prevention/Medxy AIzh2026-08-21T09:38:21-07:00卒中二级预防中的秋水仙碱：动脉粥样硬化状态对疗效的影响及临床启示 https://news.medxy.ai/ja/colchicine-stroke-prevention-2/Medxy AIja2026-08-21T09:37:59-07:00動脈硬化の有無で考える脳卒中後のコルヒチン二次予防：臨床エビデンスと実臨床への示唆 https://news.medxy.ai/vi/65798-2/Medxy AIvi2026-08-21T09:37:32-07:00Tác động của việc giảm ≥50% nồng độ cholesterol lipoprotein tỷ trọng thấp so với ban đầu ở bệnh nhân đột quỵ do thiếu máu cục bộ https://news.medxy.ai/zh/ldl-c-targets-stroke/Medxy AIzh2026-08-21T09:35:07-07:00缺血性卒中中LDL-C降幅目标如何优化？基线降低≥50%的临床意义 https://news.medxy.ai/ja/ldl-c-reduction-strategy-2/Medxy AIja2026-08-21T09:34:42-07:00虚血性脳卒中におけるLDL-C低下戦略の最適化：ベースラインから50％以上低下を達成する意義 https://news.medxy.ai/vi/ldl-c-reduction-strategy/Medxy AIvi2026-08-21T09:34:19-07:00Chiến lược tối ưu hóa giảm LDL-C trong đột quỵ thiếu máu cục bộ: Tác động của việc đạt mức giảm LDL-C ≥50% so với ban đầu https://news.medxy.ai/zh/neurofilament-z-score-monitoring/Medxy AIzh2026-08-21T09:32:46-07:00基于神经丝轻链 Z 评分变化优化复发型多发性硬化的治疗监测 https://news.medxy.ai/ja/65778-2/Medxy AIja2026-08-21T09:32:23-07:00神経フィラメント軽鎖Zスコアの変化に基づく、再発型多発性硬化症患者における治療モニタリングの精緻化 https://news.medxy.ai/vi/65777-2/Medxy AIvi2026-08-21T09:31:58-07:00Hoàn thiện quy trình theo dõi điều trị ở bệnh nhân đa xơ cứng thể tái phát dựa trên những thay đổi về điểm Z của chuỗi nhẹ neurofilament https://news.medxy.ai/zh/long-term-fatigue-thyroid-cancer/Medxy AIzh2026-08-21T09:29:20-07:00分化型甲状腺癌生存者的长期疲劳：早期预测因素与TSH抑制无关 https://news.medxy.ai/ja/thyroid-cancer-fatigue/Medxy AIja2026-08-21T09:28:52-07:00分化型甲状腺癌サバイバーの長期倦怠感：早期予測因子とTSH抑制の非関連 https://news.medxy.ai/vi/fatigue-thyroid-cancer-survivors/Medxy AIvi2026-08-21T09:27:44-07:00Mệt mỏi kéo dài ở người sống sót sau ung thư tuyến giáp biệt hóa: yếu tố dự báo sớm và vai trò không đáng kể của ức chế thyrotropin https://news.medxy.ai/zh/dulaglutide-vs-insulin/Medxy AIzh2026-08-21T09:24:44-07:00Dulaglutide 优于胰岛素：改善地中海贫血相关糖尿病青少年的血糖控制与代谢健康 https://news.medxy.ai/ja/dulaglutide-insulin-comparison/Medxy AIja2026-08-21T09:24:19-07:00サラセミア関連糖尿病の思春期患者におけるデュラグルチドとインスリンの比較：高リスク集団の血糖管理と代謝改善をめざして https://news.medxy.ai/vi/dulaglutide-vs-insulin-thalassemia/Medxy AIvi2026-08-21T09:23:51-07:00Dulaglutide so với insulin ở thanh thiếu niên mắc đái tháo đường do thalassemia: Cải thiện kiểm soát đường huyết và sức khỏe chuyển hóa ở nhóm nguy cơ cao https://news.medxy.ai/zh/menopause-thyroid-changes/Medxy AIzh2026-08-21T09:21:27-07:00绝经过渡期与甲状腺功能：中年女性变化究竟是衰老还是绝经所致？ https://news.medxy.ai/ja/menopause-thyroid-function/Medxy AIja2026-08-21T09:21:08-07:00更年期移行と甲状腺機能：中年女性における“加齢以外の影響”を読み解く https://news.medxy.ai/vi/menopause-thyroid-function-2/Medxy AIvi2026-08-21T09:20:45-07:00Chuyển tiếp mãn kinh và chức năng tuyến giáp: Phân định tác động vượt ra ngoài lão hóa ở phụ nữ trung niên https://news.medxy.ai/ja/mir-1-3p-adrenal-puberty/Medxy AIja2026-08-21T09:18:29-07:00循環miR-1-3pは副腎性思春期に先行し、プロテインキナーゼCシグナルを介して副腎皮質ステロイド産生を制御する https://news.medxy.ai/vi/mir13p-adrenarche-steroid/Medxy AIvi2026-08-21T09:18:07-07:00miR-1-3p lưu hành xuất hiện sớm trước adrenarche và điều biến quá trình sinh steroid ở vỏ thượng thận qua tín hiệu protein kinase C https://news.medxy.ai/zh/supar-diabetes-inflammation/Medxy AIzh2026-08-21T09:16:22-07:00suPAR：超越 hs-CRP 的 2 型糖尿病合并冠心病残余炎症风险新标志物 https://news.medxy.ai/ja/65713-2/Medxy AIja2026-08-21T09:15:51-07:00冠動脈疾患を合併する2型糖尿病患者において、suPARはhs-CRPを超えて治療抵抗性の炎症リスクを特定する：BARI 2D試験の付随解析 https://news.medxy.ai/vi/65712-2/Medxy AIvi2026-08-21T09:15:18-07:00suPAR xác định nguy cơ viêm kháng điều trị vượt trội so với hs-CRP ở bệnh nhân đái tháo đường tuýp 2 kèm bệnh động mạch vành: Một phân tích bổ sung từ nghiên cứu BARI 2D https://news.medxy.ai/zh/diabetes-cost-age-differences/Medxy AIzh2026-08-21T09:12:50-07:00糖尿病超额医疗负担的年龄差异：不止于传统并发症 https://news.medxy.ai/ja/diabetes-medical-burden/Medxy AIja2026-08-21T09:12:30-07:00糖尿病が年齢別にもたらす過剰な医療負担：従来型合併症を超えて https://news.medxy.ai/vi/diabetes-health-burden/Medxy AIvi2026-08-21T09:12:07-07:00Gánh nặng y tế vượt mức do đái tháo đường theo từng nhóm tuổi: Không chỉ dừng ở các biến chứng kinh điển https://news.medxy.ai/zh/left-atrial-dysfunction-vutrisiran/Medxy AIzh2026-08-21T09:10:07-07:00转甲状腺素蛋白淀粉样变性心肌病中的左心房功能障碍与Vutrisiran疗效：来自HELIOS-B试验的启示 https://news.medxy.ai/ja/left-atrial-function-vutrisiran/Medxy AIja2026-08-21T09:09:41-07:00トランスサイレチンアミロイドーシス心筋症における左房機能障害とvutrisiranの有効性：HELIOS-B試験からの知見 https://news.medxy.ai/vi/65684-2/Medxy AIvi2026-08-21T09:09:16-07:00Cấu trúc và chức năng tâm nhĩ trái, kết cục lâm sàng và hiệu quả của Vutrisiran ở bệnh nhân mắc bệnh amyloidosis do transthyretin kèm bệnh cơ tim: Phân tích thứ cấp từ thử nghiệm lâm sàng ngẫu nhiên HELIOS-B https://news.medxy.ai/zh/runx1-endothelial-mesenchymal-transdifferentiation/Medxy AIzh2026-08-21T09:06:20-07:00RUNX1驱动的内皮-间充质转分化：LMNA心肌病新的机制连接与治疗靶点 https://news.medxy.ai/ja/runx1-endothelial-mesenchymal-transition/Medxy AIja2026-08-21T09:05:55-07:00RUNX1が導く内皮間葉転換：LMNA心筋症における新たな機序的連結と治療標的 https://news.medxy.ai/vi/65665-2/Medxy AIvi2026-08-21T09:05:25-07:00Quá trình chuyển đổi từ tế bào nội mô sang tế bào trung mô do RUNX1 thúc đẩy góp phần vào sự tái cấu trúc trong bệnh cơ tim do đột biến gen LMNA https://news.medxy.ai/zh/single-cell-immunology/Medxy AIzh2026-08-21T09:02:17-07:00单细胞多组学揭示心血管疾病中隐匿的免疫特征 https://news.medxy.ai/ja/single-cell-multiomics-cardiovascular/Medxy AIja2026-08-21T09:01:59-07:00単一細胞マルチオミクスで解き明かす、心血管疾患に潜む免疫シグネチャー https://news.medxy.ai/vi/immune-signatures-heart/Medxy AIvi2026-08-21T09:01:33-07:00Khám phá các dấu ấn miễn dịch ẩn trong bệnh tim mạch bằng single-cell multi-omics https://news.medxy.ai/zh/diabetes-asymptomatic-heart-failure/Medxy AIzh2026-08-21T08:59:14-07:00揭开糖尿病中的无症状心力衰竭：TARTAN-HF试验带来的新启示 https://news.medxy.ai/ja/65645-2/Medxy AIja2026-08-21T08:58:54-07:00未診断の心不全を特定するための糖尿病ハイリスク患者を対象とした標的型評価（TARTAN-HF） https://news.medxy.ai/vi/silent-heart-failure-diabetes/Medxy AIvi2026-08-21T08:58:31-07:00Giải mã suy tim thầm lặng ở bệnh nhân đái tháo đường: Những phát hiện từ thử nghiệm TARTAN-HF https://news.medxy.ai/zh/ai-ecg-screening/Medxy AIzh2026-08-21T08:55:49-07:00社区结构性心脏病的AI-ECG筛查：PREVUE-VALVE研究揭示真实世界应用边界 https://news.medxy.ai/ja/ai-ecg-heart-disease-3/Medxy AIja2026-08-21T08:55:31-07:00地域での構造的心疾患検出におけるAI-ECG：PREVUE-VALVE研究で実臨床への適用性を検証 https://news.medxy.ai/vi/ai-ecg-heart-disease-2/Medxy AIvi2026-08-21T08:55:12-07:00AI-ECG phát hiện bệnh tim cấu trúc tại cộng đồng: Đánh giá tính ứng dụng thực tế trong nghiên cứu PREVUE-VALVE https://news.medxy.ai/zh/semaglutide-effects/Medxy AIzh2026-08-21T08:53:31-07:00Semaglutide对超重患者炎症与心血管风险的影响：来自SELECT试验的启示 https://news.medxy.ai/ja/semaglutide-inflammation-cvd/Medxy AIja2026-08-21T08:53:07-07:00過体重患者におけるセマグルチドの炎症と心血管リスクへの影響：SELECT試験からの示唆 https://news.medxy.ai/vi/semaglutide-cardiovascular-inflammation/Medxy AIvi2026-08-21T08:52:41-07:00Semaglutide ảnh hưởng thế nào đến viêm và nguy cơ tim mạch ở bệnh nhân thừa cân: Góc nhìn từ thử nghiệm SELECT https://news.medxy.ai/zh/metrnl-cd36-anti-thrombotic/Medxy AIzh2026-08-21T08:50:40-07:00Metrnl：通过靶向CD36抑制血小板活化的新型抗血栓与心肌损伤保护因子 https://news.medxy.ai/ja/metrnl-cd36-thrombosis/Medxy AIja2026-08-21T08:50:18-07:00Metrnl：CD36を標的として血栓形成と急性心筋障害を抑える新規血小板活性化抑制因子 https://news.medxy.ai/vi/metrnl-platelet-inhibition/Medxy AIvi2026-08-21T08:49:53-07:00Metrnl: Chất ức chế mới của hoạt hóa tiểu cầu nhắm vào CD36 để giảm huyết khối và tổn thương cơ tim cấp https://news.medxy.ai/zh/meningioma-management/Medxy AIzh2026-08-21T08:47:40-07:00脑膜瘤管理需重新审视：发病率激增，治疗稳定，影像随访过度 https://news.medxy.ai/ja/meningioma-management-review/Medxy AIja2026-08-21T08:47:18-07:00髄膜腫管理を見直す：治療は横ばいでも発生率が急増、画像サーベイランスは過剰か https://news.medxy.ai/vi/meningioma-management-review-2/Medxy AIvi2026-08-21T08:46:55-07:00Quản lý u màng não cần được nhìn lại: tỷ lệ mắc tăng mạnh trong khi điều trị ổn định và giám sát hình ảnh vẫn dày đặc https://news.medxy.ai/zh/federal-industry-funding/Medxy AIzh2026-08-21T08:22:46-07:00美国癌症临床试验中联邦与产业资助的角色：差异与互补 https://news.medxy.ai/ja/us-cancer-trials-role/Medxy AIja2026-08-21T08:22:26-07:00米国のがん臨床試験における連邦と産業界スポンサーの役割を読み解く https://news.medxy.ai/vi/federal-vs-industry-funding/Medxy AIvi2026-08-21T08:22:00-07:00Phân định vai trò của tài trợ liên bang và tài trợ từ ngành trong các thử nghiệm lâm sàng ung thư tại Hoa Kỳ https://news.medxy.ai/ovarian-tissue-cryopreservation-after-hematopoietic-stem-cell-transplantation-a-viable-fertility-preservation-strategy-in-selected-females/Medxy AIen2026-08-20T15:16:40-07:00Ovarian Tissue Cryopreservation After Hematopoietic Stem Cell Transplantation: A Viable Fertility Preservation Strategy in Selected Females https://news.medxy.ai/mid-to-long-term-clinical-outcomes-of-b-lite-lightweight-breast-implants-in-primary-augmentation-a-prospective-multicenter-study/Medxy AIen2026-08-20T15:16:27-07:00Mid- to Long-term Clinical Outcomes of B-Lite Lightweight Breast Implants in Primary Augmentation: A Prospective Multicenter Study https://news.medxy.ai/early-respiratory-infection-burden-and-atopic-dermatitis-in-childhood-insights-from-prospective-birth-cohorts/Medxy AIen2026-08-20T15:16:11-07:00Early Respiratory Infection Burden and Atopic Dermatitis in Childhood: Insights from Prospective Birth Cohorts https://news.medxy.ai/psychotherapy-for-impact-of-killing-during-war-advancing-treatment-of-ptsd-and-moral-injury-in-veterans/Medxy AIen2026-08-20T15:15:58-07:00Psychotherapy for Impact of Killing During War: Advancing Treatment of PTSD and Moral Injury in Veterans https://news.medxy.ai/early-b-cell-depletion-patterns-predict-long-term-rituximab-outcomes-and-refractory-disease-in-rheumatoid-arthritis/Medxy AIen2026-08-20T15:15:47-07:00Early B-Cell Depletion Patterns Predict Long-Term Rituximab Outcomes and Refractory Disease in Rheumatoid Arthritis https://news.medxy.ai/rotavirus-vaccine-significantly-reduces-mortality-from-rotavirus-associated-acute-gastroenteritis-in-children-under-5-insights-from-the-mnsster-v-global-dataset/Medxy AIen2026-08-20T15:15:32-07:00Rotavirus Vaccine Significantly Reduces Mortality from Rotavirus-Associated Acute Gastroenteritis in Children Under 5: Insights from the MNSSTER-V Global Dataset https://news.medxy.ai/efficacy-and-outcomes-of-short-course-perioperative-antiviral-prophylaxis-in-hepatitis-c-viremic-donor-kidney-transplantation/Medxy AIen2026-08-20T15:15:20-07:00Efficacy and Outcomes of Short-Course Perioperative Antiviral Prophylaxis in Hepatitis C Viremic Donor Kidney Transplantation https://news.medxy.ai/impact-of-corneal-posterior-to-anterior-radius-ratio-on-intraocular-lens-power-calculations-rethinking-the-role-of-total-keratometry/Medxy AIen2026-08-20T15:15:07-07:00Impact of Corneal Posterior-to-Anterior Radius Ratio on Intraocular Lens Power Calculations: Rethinking the Role of Total Keratometry https://news.medxy.ai/does-industry-influence-persist-financial-conflicts-and-adm-outcomes-after-the-2021-fda-safety-alert-a-case-report-analysis/Medxy AIen2026-08-20T15:14:52-07:00Does Industry Influence Persist? Financial Conflicts and ADM Outcomes After the 2021 FDA Safety Alert: A Case Report Analysis https://news.medxy.ai/impact-of-emergency-department-pediatric-readiness-and-inpatient-services-on-child-mortality-a-decade-long-cohort-study/Medxy AIen2026-08-20T15:14:39-07:00Impact of Emergency Department Pediatric Readiness and Inpatient Services on Child Mortality: A Decade-Long Cohort Study https://news.medxy.ai/bridging-the-gap-how-transportation-barriers-impact-primary-care-attendance-and-the-role-of-telemedicine/Medxy AIen2026-08-20T15:14:27-07:00Bridging the Gap: How Transportation Barriers Impact Primary Care Attendance and the Role of Telemedicine https://news.medxy.ai/longitudinal-heart-stress-changes-and-cardiovascular-risk-in-older-adults-insights-from-nt-probnp-dynamics/Medxy AIen2026-08-20T15:14:14-07:00Longitudinal Heart Stress Changes and Cardiovascular Risk in Older Adults: Insights from NT-proBNP Dynamics https://news.medxy.ai/transforming-lymphoma-outcomes-through-international-real-world-data-collaborations-the-global-lymphoma-registry-alliance-roadmap/Medxy AIen2026-08-20T15:14:02-07:00Transforming lymphoma outcomes through international real-world data collaborations: the Global Lymphoma Registry Alliance roadmap https://news.medxy.ai/effective-relief-for-recurrent-acute-rhinosinusitis-insights-from-a-randomized-clinical-trial-on-endoscopic-sinus-surgery/Medxy AIen2026-08-20T15:13:48-07:00Effective Relief for Recurrent Acute Rhinosinusitis: Insights from a Randomized Clinical Trial on Endoscopic Sinus Surgery https://news.medxy.ai/impact-of-icu-room-design-on-patient-outcomes-mortality-and-length-of-stay-insights-from-a-large-cohort-study/Medxy AIen2026-08-20T15:13:29-07:00Impact of ICU Room Design on Patient Outcomes: Mortality and Length of Stay Insights from a Large Cohort Study https://news.medxy.ai/advancing-perioperative-risk-stratification-predicting-acute-kidney-injury-following-lung-transplantation/Medxy AIen2026-08-20T15:13:16-07:00Advancing Perioperative Risk Stratification: Predicting Acute Kidney Injury Following Lung Transplantation https://news.medxy.ai/late-onset-leber-hereditary-optic-neuropathy-environmental-triggers-genetic-factors-and-visual-recovery-insights-from-a-large-italian-cohort/Medxy AIen2026-08-20T15:13:02-07:00Late-Onset Leber Hereditary Optic Neuropathy: Environmental Triggers, Genetic Factors, and Visual Recovery Insights from a Large Italian Cohort https://news.medxy.ai/exploring-the-role-of-autoimmune-conditions-in-acute-interstitial-pneumonia-clinical-outcomes-and-implications/Medxy AIen2026-08-20T15:12:47-07:00Exploring the Role of Autoimmune Conditions in Acute Interstitial Pneumonia: Clinical Outcomes and Implications https://news.medxy.ai/congenital-tuberculosis-in-a-2-week-old-neonate-with-an-asymptomatic-mother/Medxy AIen2026-08-20T15:12:11-07:00Congenital Tuberculosis in a 2-Week-Old Neonate With an Asymptomatic Mother https://news.medxy.ai/pre-diagnostic-low-normal-immunoglobulin-levels-identify-early-clonal-b-cell-dysregulation-and-cll-susceptibility-insights-from-a-large-retrospective-cohort/Medxy AIen2026-08-20T15:11:54-07:00Pre-Diagnostic Low-Normal Immunoglobulin Levels Identify Early Clonal B-cell Dysregulation and CLL Susceptibility: Insights from a Large Retrospective Cohort https://news.medxy.ai/dual-targeted-anti-bcma-gprc5d-car-t-cell-therapy-shows-promise-in-relapsed-refractory-multiple-myeloma-with-extraosseous-extramedullary-disease/Medxy AIen2026-08-20T15:11:37-07:00Dual-Targeted Anti-BCMA/GPRC5D CAR T-Cell Therapy Shows Promise in Relapsed/Refractory Multiple Myeloma with Extraosseous Extramedullary Disease